CAS: 548-77-6; 5,7-Dihydroxy-3-(4-Hydroxyphenyl)-6-Methoxy-4H-Chromen-4-One

化学文摘社编号548-77-6,主要存在于各种植物物种中,特别是草药Belamcanda中原的根部; 甲草胺呈现出一系列生物活动,包括抗氧化剂,抗炎和潜在的抗癌特性,使其对药理学研究感兴趣; 该化合物的特点是其芬片结构,有助于其再活动以及与生物系统的互动; 甲草胺是有机溶剂的溶液,而且水中的溶性有限,许多氟草类的典型特征是该物质化学配方反映碳,氢和氧原子的具体安排,有助于其独特的特性和生物影响; 对甲草胺的研究继续探索其治疗潜力,特别是在慢性病和健康促进方面. 总的来说,磷素是天然产品研究及其医学应用中的一种重要化合物.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号2345-17-7 葛花苷元 | CAS号27181-83-5 2-(4-hydroxyphe... | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号14191-95-8 对羟基苯乙腈 | CAS号64-18-6 甲酸 | CAS号156-38-7 对羟基苯乙酸 | CAS号487-71-8 1,3,5-三羟基2-甲氧基苯 | CAS号13539-26-9 5,6,7-trihydrox...

合成工艺路线路线简述

    📜对羟基苯乙腈置于盐酸,三氟化硼乙醚,甲基磺酰氯体系中,用 乙醚 作为反应溶剂,化学反应 27.0H,反应生成 鸢尾黄素
    参考文献:Polyphenols Based On Isoflavones As Inhibitors Of Helicobacter Pylori Urease
    标题:Polyphenols Based On Isoflavones As Inhibitors Of Helicobacter Pylori Urease
    摘要:Twenty Polyphenols Were Synthesized And Evaluated For Their Effect On Helicobacter Pylori Urease. Among These Compounds,4-(P-Hydroxyphenethyl)Pyrogallol (15) (Ic50 = 0.03 Mm) And 7,8,4'-Trihydroxyisoflavone (19) (Ic50 = 0.14 Mm) Showed Potent Inhibitory Activities,And Inhibited Helicobacter Pylori Urease In A Time-Dependent Manner. The Structure-Activity Relationship Of These Polyphenols Revealed: The Two Ortho Hydroxyl Groups Were Essential For Inhibitory Activity Of Polyphenol. When The C-Ring Of Isoflavone Was Broken,The Inhibitory Activity Markedly Decreased. As For Deoxybenzoin,The Carboxyl Group Was Clearly Detrimental. (C) 2007 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Bmc.2007.03.045

    海关参考信息

    专利信息


    专利号:US-2005080260-A1
    优先权日:2003-04-22
    标 题 :Preparation of prodrugs for selective drug delivery
    发明人:MILLS RANDELL L; WU GUO-ZHANG
    摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

    专利号:US-2022133840-A1
    优先权日:2020-10-30
    标题:Use of microcystin in preparation of drug for preventing or treating organ and tissue fibrosis diseases
    发明人:WANG YAPING; XU LIZHI; WANG JIE; Zhao qingya
    权利人:NANJING UNIVERSITY OF TECHNOLOGY
    摘要:Use of microcystins having a monocyclic heptapeptide structure in preparation of drugs for preventing or treating organ and tissue fibrosis diseases. Preferably, the microcystins are microcystin-LR with amino acids at positions 2 and 4 of a monocyclic heptapeptide structure thereof being leucine and arginine respectively, or are microcystin-RR with amino acids at positions 2 and 4 thereof being both arginine. Also provided is a method for inhibiting myofibroblast differentiation and collagen synthesis. The method is implemented by inhibiting a TGF-β/Smad signaling pathway by using one or more microcystins.

    专利号:US-2007232495-A1
    优先权日:2006-03-24
    标题:Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof
    发明人:NAPPA ALVARO O; LORENZINI FELIPE C; SANHUEZA ANDRES L
    权利人:NAPPA ALVARO O; LORENZINI FELIPE C; SANHUEZA ANDRES L
    摘要:The invention is related to compositions and methods that naturally protect plant tissues against ultraviolet radiation and temperature, thus giving protection against sunburn to plants, plant parts, fruits and/or flowers during their development. The invention is also related to compositions and methods to naturally improve the color of plants, plant parts, fruits and/or flowers by inducing the natural synthesis of flavonoids and anthocyanins present in plants. Likewise, the present invention is directed to improving the nutritional value of plants, plant parts, fruits and/or flowers by increasing the normal levels of polyphenolic compounds, especially flavonoids, present therein. Additionally, the present invention is related to compositions and methods that give more resistance to plants, plant parts, fruits and/or flowers against pathogens as bacteria and fungi. Finally, the present invention is related to plants, plant parts, fruits, flowers and/or propagating material treated with the compositions described in the present document.

    专利号:US-8361516-B2
    优先权日:2006-08-03
    标 题:Composition comprising sarsasapogenin
    发明人:LINTNER KARL; MAS CHAMBERLIN CLAIRE
    权利人:SEDERMA SA; LINTNER KARL; MAS CHAMBERLIN CLAIRE
    摘要:The présent invention relates to a composition comprising sarsasapogenin or a plant extract containing it in order to improve the gêneral state of the skin and in particular to improve and/or embellish any part of the body showing a déficit in lipids. More particularly, the invention is directed to a cosmetic method to improve the figure, comprising the step of topically applying to the skin a cosmetic or dermopharmaceutical composition comprising sarsasapogenin to favour the expansion and/or the formation of the subcutaneous adipose tissue, and/or to favour the lipid synthesis in the epidermis.

    专利号:US-7151196-B2
    优先权日:2004-11-01
    标题 :Estrogen receptor modulators
    发明人:WILKENING ROBERT R; FRIED AMY
    权利人:MERCK & CO INC
    摘要:The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, metastatic bone disease, Paget's disease, periodontal disease, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, age-related mild cognitive impairment, cerebral degenerative disorders, restenosis, gynecomastia, vascular smooth muscle cell proliferation, obesity, incontinence, inflammation, inflammatory bowel disease, irritable bowel syndrome, sexual dysfunction, hypertension, retinal degeneration and cancer, in particular of the breast, uterus and prostate.

    专利号:CN-115612114-A
    优先权日:2021-07-14
    标 题:Method and application of copolymer film and its enzymatic self-assembly synthesis

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Lee SY, Kim GT, Yun HM, Kim YC, Kwon IK, Kim EC. Tectorigenin Promotes Osteoblast Differentiation and in vivo Bone Healing, but Suppresses Osteoclast Differentiation and in vivo Bone Resorption. Mol Cells. 2018 May 15. doi: 10.14348/molcells.2018.0056. [Epub ahead of print] doi: 10.1016/j.biopha.2018.04.070. [Epub ahead of print] pii: E884. doi: 10.3390/molecules23040884. doi: 10.3892/mmr.2017.8313. Epub 2017 Dec 19. doi: 10.3892/etm.2017.5049. Epub 2017 Aug 28.
    7: Applová L, Karlíčková J, Říha M, Filipský T, Macáková K, Spilková J, Mladěnka P. The isoflavonoid tectorigenin has better antiplatelet potential than acetylsalicylic acid. Phytomedicine. 2017 Nov 15;35:11-17. doi: 10.1016/j.phymed.2017.08.023. Epub 2017 Aug 24. doi: 10.19540/j.cnki.cjcmm.20161222.030. Chinese. doi: 10.1242/bio.024562.
    10: Bulgakov VP, Vereshchagina YV, Veremeichik GN. Anticancer Polyphenols from Cultured Plant Cells: Production and New Bioengineering Strategies. Curr Med Chem. 2017 Jun 8. doi: 10.2174/0929867324666170609080357. [Epub ahead of print] doi: 10.1002/jssc.201700258. Epub 2017 Jun 1. doi: 10.1080/10717544.2017.1284946. doi: 10.1016/j.jchromb.2017.02.009. Epub 2017 Feb 14. doi: 10.15430/JCP.2016.21.4.257. Epub 2016 Dec 30.

    合成参考文献


    参考文献:10.1248/bpb.29.1202
    摘要:Shin JE, Bae EA, Lee YC, Ma JY, Kim DH. Estrogenic effect of main components kakkalide and tectoridin of Puerariae Flos and their metabolites. Biol Pharm Bull. 2006 Jun;29(6):1202–6. doi: 10.1248/bpb.29.1202.
    参考文献:10.1007/bf02976631
    摘要:Jung SH, Lee YS, Lee S, Lim SS, Kim YS, Shin KH. Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues. Arch Pharm Res. 2002 Jun;25(3):306–12. doi: 10.1007/bf02976631.
    参考文献:10.1007/bf02976633
    摘要:Park KY, Jung GO, Choi J, Lee KT, Park HJ. Potent antimutagenic and their anti-lipid peroxidative effect of kaikasaponin III and tectorigenin from the flower of Pueraria thunbergiana. Arch Pharm Res. 2002 Jun;25(3):320–4. doi: 10.1007/bf02976633.
    参考文献:10.1016/j.phymed.2004.01.003
    摘要:Seidlová-Wuttke D, Hesse O, Jarry H, Rimoldi G, Thelen P, Christoffel V, Wuttke W. Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities. Phytomedicine. 2004 Jul;11(5):392–403. doi: 10.1016/j.phymed.2004.01.003.
    参考文献:10.1016/j.jep.2008.04.006
    摘要:Fang R, Houghton PJ, Hylands PJ. Cytotoxic effects of compounds from Iris tectorum on human cancer cell lines. J Ethnopharmacol. 2008 Jul 23;118(2):257–63. doi: 10.1016/j.jep.2008.04.006.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知